NFKB1 and glioblastoma: Furthermore, we found that H2AFJ upregulation may be associated with the proneural-mesenchymal transition, which correlates with TMZ resistance [20] and likely activates TNF-α/NF-κB pathway which has been shown to mediate mesenchymal differentiation and therapeutic resistance in GBM cells [21].